CSIMarket
 


Regencell Bioscience Holdings Limited  (NASDAQ: RGC)

Regencell Bioscience Holdings Limited's Total Debt to Equity

RGC's quarterly Total Debt to Equity and Total Debt, Equity growth




Due to debt repayement of 0% Regencell Bioscience Holdings Limited improved Total Debt to Equity in fourth quarter 2025 to 0, a new company low.

Within Legal Cannabis industry Regencell Bioscience Holdings Limited achieved the lowest Total Debt to Equity in the fourth quarter 2025. While Total Debt to Equity total ranking has deteriorated compared to the third quarter 2025 from to 16 .

Explain Debt to Equity Ratio?
How much Total Debts RGC´s has?
What are RGC´s Equity?


RGC Total Debt to Equity (Jun 30 2025)
Q4
0
Q3
0
Q2
0
Q1
(Jun 30 2023)
Q4
Y / Y Equity Change -59.46 % -59.46 % -59.46 % -59.46 % -29.81 %
Y / Y Total Debt Change -75.98 % -75.98 % -75.98 % -75.98 % -
Total Debt to Equity MRQ 0 0 0 0 0
RGC's Total Ranking # 16 # # # #
Seq. Equity Change 0 % 0 % 0 % -59.46 % 0 %
Seq. Total Debt Change 0 % 0 % 0 % -75.98 % 0 %



Total Debt to Equity fourth quarter 2025 Company Ranking
Within: No.
Legal Cannabis Industry # 1
Consumer Non Cyclical Sector # 2
Overall Market # 16


Total Debt to Equity Statistics
High Average Low
0 0 0
(Jun 30 2023)   (Jun 30 2025)




Financial Statements
Regencell Bioscience Holdings Limited's Equity $ 5 Millions Visit RGC's Balance sheet
Regencell Bioscience Holdings Limited's Total Debt $ 0 Millions Visit RGC's Balance sheet
Source of RGC's Sales Visit RGC's Sales by Geography


Cumulative Regencell Bioscience Holdings Limited's Total Debt to Equity

RGC's Total Debt to Equity for the trailling 12 Months

RGC Total Debt to Equity

(Jun 30 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Jun 30 2023)
12 Months
Y / Y Equity TTM Growth -59.46 % -49.91 % -42.04 % -35.43 % -29.81 %
Y / Y Total Debt TTM Growth -75.98 % -42.65 % 24.02 % 224.02 % -
Total Debt to Equity TTM 0 0 0 0 0
Total Ranking TTM # 1 # # # #
Seq. Equity TTM Growth -26.83 % -21.16 % -17.46 % -14.87 % -9.6 %
Seq. Total Debt TTM Growth -44.16 % -30.63 % -23.45 % -18.99 % 33.33 %


On the trailing twelve months basis Due to debt repayement of 0% Regencell Bioscience Holdings Limited